Apogee Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -408 | 400 | -400 | -400 |
EBITDA | -73,624 | -68,919 | -64,559 | -65,625 |
EBIT | -74,032 | -69,325 | -64,959 | -66,024 |
Net Income | -74,111 | -69,387 | -65,021 | -66,096 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -55,570 | -62,751 | -54,255 | -62,797 |
Cash | 451,797 | 131,549 | 107,914 | 124,192 |
Basic Shares | 69,668 | 60,690 | 58,773 | 58,428 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,418 | -189 | ||
EBITDA | -254,147 | -181,939 | -74,967 | -39,785 |
EBIT | -255,565 | -182,128 | -83,985 | -64,247 |
Net Income | -255,843 | -182,146 | -83,985 | -39,785 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -232,597 | -172,326 | -74,928 | -16,427 |
Cash | 131,549 | 141,789 | 118,316 | 151,890 |
Basic Shares | 60,690 | 55,193 | 50,655 | 50,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.06 |
2025-12-31 | -$1.03 |
2025-09-30 | -$1.11 |
2025-06-30 | -$1.13 |